The Albert Einstein College of Medicine of Yeshiva University is a premier, research-intensive medical school dedicated to innovative biomedical investigation and to the development of ethical and compassionate physicians and scientists. Inspired by the words of our namesake, we welcome students, faculty and staff from diverse backgrounds who strive to enhance human health in the community and beyond.
ALBERT EINSTEIN COLLEGE OF MEDICINE: SCIENCE AT THE HEART OF MEDICINE
Albert Einstein College of Medicine offers one of the nation’s largest programs for medical education. During the 2012-2013 academic year, the College of Medicine is home to 742 M.D. students, 245 Ph.D. students, 116 students in the combined M.D./Ph.D. program, and 360 postdoctoral research fellows at our Belfer Institute for Advanced Biomedical Studies. More than 8,000 Einstein alumni are among the nation’s foremost clinicians, biomedical scientists, and medical educators.
When the medical school opened its doors in 1955, the New York Times was already noting that “the new medical school’s distinguished and talented faculty assured the institution of a place in the ranks of the great medical schools in the world.” This prophecy has been more than fulfilled in the ensuing years.
Among its pioneering educational initiatives, Einstein was one of the first major medical schools to integrate bedside experience with learning, bringing first-year students into contact with patients and linking classroom study to case experience. Einstein also led the way in the development of bioethics as an accepted academic discipline in medical school curricula, was the first private medical school in New York City to establish an academic department of family medicine, and was the first to create a residency program in internal medicine with an emphasis on women’s health.
While education is at the heart of Einstein’s mission, it is biomedical research that drives the College of Medicine’s growth. The College of Medicine has more than 2,000 full-time faculty members located on its Jack and Pearl Resnick campus and at its clinical affiliates.
Long a national leader in biomedical research support from the Federal government, during 2012, Einstein faculty received nearly $160 million in funding from the National Institutes of Health. In addition, the NIH funds major research centers at Einstein in diabetes, cancer, liver disease, and AIDS. Other areas of focus include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities.
Einstein also was the only New York City institution selected to participate in the Federal government’s landmark Women’s Health Initiative, and is currently one of just four sites nationwide taking part in alarge-scale study of the health status of the Hispanic/Latino community in the Bronx, supported by the NIH.
The College of Medicine's partnership with Montefiore Medical Center, its University Hospital and academic medical center, includes four jointly run Centers of Excellence and is further strengthened by the dual appointments of faculty and physicians across both institutions – enhancing synergies and collaborations for research, teaching and patient care. This partnership allows for an increasing focus on bench-to-bedside research, through which discoveries in Einstein’s laboratories lead to therapies and treatments for patients on an accelerated timetable.
Through its affiliations with Montefiore; Jacobi Medical Center, its founding hospital; and five other hospital systems in the Bronx, Manhattan, Long Island and Brooklyn, the College of Medicine runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States.
In addition to Montefiore and Jacobi, Einstein medical students may rotate through clinical clerkships at Bronx-Lebanon Hospital and St. Barnabas Hospital in the Bronx, Beth Israel Medical Center in Manhattan, North Shore-LIJ Health System on Long Island, and Maimonides Medical Center in Brooklyn. The broad geographical reach of Einstein’s residency programs is a distinction unique among New York City medical schools.
Looking to the future, the College of Medicine has embarked on a major expansion program that effectively doubled the size of its campus. Central to this expansion, and a critical part of Einstein’s campus master plan, was the June 2008 opening of the Michael F. Price Center for Genetic and Translational Medicine/Harold and Muriel Block Research Pavilion, a 223,000 square-foot biomedical research building that houses 40 laboratories. These new state-of-the-art facilities bring together world-class scientists and the most advanced cutting-edge technology to facilitate the “translation” of discoveries at the molecular level to the actual treatment, cure and prevention of disease.
As we enter what will surely be a golden age of medicine, this medical school remains steadfast in its core missions: educating students to become caring as well as curing physicians; fostering pioneering research programs in biomedical and translational research; and delivering superb patient care. We continue to be guided by the high academic and humanistic values exemplified by our namesake, Albert Einstein, as we shape a better future for the health of people everywhere.
The College of Medicine is a nonsectarian institution, which from its inception has welcomed students of all creeds and races — an attribute that Dr. Einstein took great pride in when consenting to the use of his name in conjunction with the medical school.